[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CS226183B2 - Method of preparing n-ethyl-2-(2,6-dialkoxybenzamidomethyl)-pyrrolidine derivatives - Google Patents

Method of preparing n-ethyl-2-(2,6-dialkoxybenzamidomethyl)-pyrrolidine derivatives Download PDF

Info

Publication number
CS226183B2
CS226183B2 CS791902A CS190279A CS226183B2 CS 226183 B2 CS226183 B2 CS 226183B2 CS 791902 A CS791902 A CS 791902A CS 190279 A CS190279 A CS 190279A CS 226183 B2 CS226183 B2 CS 226183B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
acid
chlorine
mol
Prior art date
Application number
CS791902A
Other languages
Czech (cs)
English (en)
Inventor
Goesta L Florvall
Sven O Oegren
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of CS226183B2 publication Critical patent/CS226183B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
CS791902A 1978-03-23 1979-03-22 Method of preparing n-ethyl-2-(2,6-dialkoxybenzamidomethyl)-pyrrolidine derivatives CS226183B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7803411A SE411118B (sv) 1978-03-23 1978-03-23 Ett forfarande for framstellning av 2,6-dialkoxibensamider med terapentiska egenskaper

Publications (1)

Publication Number Publication Date
CS226183B2 true CS226183B2 (en) 1984-03-19

Family

ID=20334412

Family Applications (1)

Application Number Title Priority Date Filing Date
CS791902A CS226183B2 (en) 1978-03-23 1979-03-22 Method of preparing n-ethyl-2-(2,6-dialkoxybenzamidomethyl)-pyrrolidine derivatives

Country Status (26)

Country Link
US (1) US4232037A (es)
EP (1) EP0004831B1 (es)
JP (1) JPS585910B2 (es)
AT (1) AT374173B (es)
AU (1) AU525475B2 (es)
CA (1) CA1101873A (es)
CS (1) CS226183B2 (es)
DD (1) DD143605A5 (es)
DE (1) DE2964774D1 (es)
DK (1) DK157844C (es)
ES (1) ES478871A1 (es)
FI (1) FI73979C (es)
HK (1) HK77085A (es)
HU (1) HU177793B (es)
IE (1) IE48491B1 (es)
LT (1) LT2246B (es)
LU (1) LU88308I2 (es)
MX (1) MX9203148A (es)
MY (1) MY8500407A (es)
NL (1) NL930052I2 (es)
NO (1) NO152414C (es)
NZ (1) NZ189935A (es)
SE (1) SE411118B (es)
SG (1) SG51885G (es)
SU (1) SU818481A3 (es)
ZA (1) ZA79964B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8101536L (sv) * 1981-03-11 1982-09-12 Astra Laekemedel Ab Bensamid-derivat
US4470977A (en) * 1981-06-04 1984-09-11 Adria Laboratories, Inc. Antiemetic and antipsychotic agents
SE8205135D0 (sv) * 1982-09-09 1982-09-09 Astra Laekemedel Ab Benzamido-derivatives
US5240957A (en) * 1984-01-31 1993-08-31 Astra Lakemedel Akteibolag Oxysalicylamido derivatives
SE8400478D0 (sv) * 1984-01-31 1984-01-31 Astra Laekemedel Ab Oxysalicylamido derivatives
SE8503054D0 (sv) * 1985-06-19 1985-06-19 Astra Laekemedel Ab Catecholcarboxamides
DE3629598A1 (de) * 1986-08-30 1988-03-03 Boehringer Ingelheim Kg 3-brom-2,6-dimethoxibenzamide, ihre herstellung und verwendung
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
US4751236A (en) * 1987-05-20 1988-06-14 Avihou Mishniot Method for treating genital herpes
US5154913A (en) * 1987-11-19 1992-10-13 Vanderbilt University Radioiodinated benzamines method of their use as radioimaging agents
US5231099A (en) * 1991-04-15 1993-07-27 Du Pont Merck Pharmaceutical Company Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs
CA2112127A1 (en) * 1991-07-15 1993-02-04 Joseph Auerbach Novel process for aromatic bromination
US5248817A (en) * 1991-07-15 1993-09-28 Merck & Co., Inc. Process for aromatic bromination
CN104058956A (zh) * 2014-06-04 2014-09-24 蚌埠团结日用化学有限公司 3-溴-2，6二甲氧基苯甲酸合成的生产工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD67123A (es) *
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (es) * 1966-01-21 1968-05-06
BE695272A (es) * 1967-03-09 1967-09-11
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
IT1070992B (it) * 1973-12-21 1985-04-02 Italfarmaco Spa Processo per la preparazione della i etil 2 2 metossi 5 sulfamoil benzamidometil pirrolidina
CH605793A5 (es) * 1974-03-05 1978-10-13 Ile De France
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
DE2556457C3 (de) * 1974-12-18 1981-02-12 Synthelabo S.A., Paris N-(Pyrrolidin-2-yl-methyl)-2-methoxybenzamide, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
FI73979B (fi) 1987-08-31
JPS54154730A (en) 1979-12-06
ES478871A1 (es) 1979-07-01
FI73979C (fi) 1987-12-10
MX9203148A (es) 1992-07-01
SU818481A3 (ru) 1981-03-30
FI790922A (fi) 1979-09-24
JPS585910B2 (ja) 1983-02-02
MY8500407A (en) 1985-12-31
IE790630L (en) 1979-09-23
LU88308I2 (fr) 1994-05-04
DK157844B (da) 1990-02-26
NO790934L (no) 1979-09-25
EP0004831A2 (en) 1979-10-17
HK77085A (en) 1985-10-18
AT374173B (de) 1984-03-26
SG51885G (en) 1986-01-24
US4232037A (en) 1980-11-04
NO152414B (no) 1985-06-17
DD143605A5 (de) 1980-09-03
CA1101873A (en) 1981-05-26
AU4521979A (en) 1979-09-27
IE48491B1 (en) 1985-02-06
LT2246B (lt) 1993-11-15
AU525475B2 (en) 1982-11-11
SE7803411L (sv) 1979-09-24
DK157844C (da) 1990-07-30
NZ189935A (en) 1984-07-06
HU177793B (en) 1981-12-28
EP0004831A3 (en) 1979-10-31
DE2964774D1 (en) 1983-03-24
NL930052I2 (nl) 1994-01-03
SE411118B (sv) 1979-12-03
NL930052I1 (nl) 1993-09-01
DK117779A (da) 1979-09-24
ATA217779A (de) 1983-08-15
EP0004831B1 (en) 1983-02-16
NO152414C (no) 1985-09-25
ZA79964B (en) 1980-06-25

Similar Documents

Publication Publication Date Title
CS226183B2 (en) Method of preparing n-ethyl-2-(2,6-dialkoxybenzamidomethyl)-pyrrolidine derivatives
EP0507863A1 (en) Sigma receptor ligands and the use thereof
CS227019B2 (en) Method of preparing (-)-n-methyl-3-(2-methylphenyloxy)-3-phenylpropylamine
JPH07223953A (ja) 中枢神経系疾患治療用薬剤組成物
SK50192004A3 (sk) Spôsob prípravy (S)-4-amino-5-chlór-2-metoxy-N-[1-[1-(2- tetrahydrofurylkarbonyl)-4-piperidinylmethyl]-4- piperidinyl]benzamidu, farmaceutický prostriedok obsahujúci tento derivát a opis medziproduktu tohto derivátu
KR890001375B1 (ko) 벤즈아미도 유도체의 제조 방법
JPS5826754B2 (ja) サンカンシキカゴウブツノピペリジリデンユウドウタイノセイホウ
JPH08504744A (ja) アリールトリフラート及びこれに関連する化合物
PT87854B (pt) Processo para a preparacao de derivados de tio-ureia
JPS62198672A (ja) 新規三環式チアゼピン誘導体、その製造法および医薬組成物
JPS5967260A (ja) ベンズアミド誘導体
JP2010535174A (ja) Ｎ−ピペリジン−４−イルメチルアミド誘導体及びモノアミン神経伝達物質再取り込み阻害薬としてのその使用
PT703915E (pt) Xamoneline tartrato
US4237311A (en) 2-Methyl-1-(substituted)phenyl-2-propyl esters of 2-aminopropanoic acid
JPS6230762A (ja) 新規５−オキソ−１−イミダゾリジンアセトアミド誘導体
JPH08501285A (ja) Ｎ−シクロアルキルピペラジン誘導体、それらを取得する方法およびそれらを含有する薬学的組成物
UA76913C2 (uk) Фармацевтична композиція, що містить кристалічний напівгідрат метансульфонату сибутраміну
CA1109484A (en) 2,6-dialkoxybenzamides, intermediates, pharmaceutical compositions and methods for treatment of psychotic disorders
WO2004020437A1 (en) S-(+)-3-{1-[2-(2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
DK170972B1 (da) (+)-1-[(3,4,5-Trimethoxy)benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamin samt lægemidler med indhold af denne forbindelse
JP3282827B2 (ja) ３−アリール−２−（１−置換−４−ピペリジニル）−１（１−ジ）オキソ−３ｈ−ベンゾ〔ｄ〕−イソチアゾール誘導体、その製造および神経伝達物質機能のモジュレーターとしてのその使用
CS266314B2 (cs) Způsob výroby benzamidových derivátů
US8669250B2 (en) Derivatives of aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl}-methanone, their method of preparation and their use as medicinal products
PL165125B1 (pl) Sposób wytwarzania nowych zwiazków heterocyklicznych zawierajacych azot i siarke PL PL
JPH07103097B2 (ja) オキシサリチルアミド誘導体